epirubicin
Selected indexed studies
- [Epirubicin (4'-epi-adriamycin]. (Gan To Kagaku Ryoho, 1990) [PMID:2404456]
- Clinical pharmacokinetics of epirubicin. (Clin Pharmacokinet, 1994) [PMID:8070217]
- Epirubicin: a review of its intravesical use in superficial bladder cancer. (Drugs Aging, 1999) [PMID:10582777]
_Worker-drafted node — pending editorial review._
Connections
epirubicin is a side effect of
Sources
- [Epirubicin (4'-epi-adriamycin]. (1990) pubmed
- Clinical pharmacokinetics of epirubicin. (1994) pubmed
- Epirubicin: a review of its intravesical use in superficial bladder cancer. (1999) pubmed
- Epirubicin: is it like doxorubicin in breast cancer? A clinical review. (2012) pubmed
- Epirubicin in combination with the taxanes. (2001) pubmed
- Epirubicin. Clinical pharmacology and dose-effect relationship. (1993) pubmed
- Epirubicin/taxane combinations in breast cancer: experience from several Italian trials. (2001) pubmed
- Epirubicin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cancer chemotherapy. (1993) pubmed
- Epirubicin versus doxorubicin: which is the anthracycline of choice for the treatment of breast cancer? (2003) pubmed
- Epirubicin and doxorubicin: a comparison of their characteristics, therapeutic activity and toxicity. (1993) pubmed